345953-58-4Relevant academic research and scientific papers
Synthesis of 4-(1H-Azol-1-ylmethyl)benzohydrazides and their acyclic and heterocyclic derivatives
Osyanin,Purygin,Belousova
, p. 111 - 117 (2007/10/03)
4-(1H-Azol-1-ylmethyl)benzohydrazides were prepared from methyl 4-(bromomethyl)benzoate, azoles, and hydrazine hydrate. Reactions of 4-(1H-imidazol-1-ylmethyl)benzohydrazide with carbonyl compounds gave hydrazones whose tautomerism was studied. From the h
Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors
Lau, Cheuk K.,Bayly, Christopher I.,Gauthier, Jacques Yves,Li, Chun Sing,Therien, Michel,Asante-Appiah, Ernest,Cromlish, Wanda,Boie, Yves,Forghani, Farnaz,Desmarais, Sylvie,Wang, Qingping,Skorey, Kathryn,Waddleton, Deena,Payette, Paul,Ramachandran, Chidambaram,Kennedy, Brian P.,Scapin, Giovana
, p. 1043 - 1048 (2007/10/03)
A series of benzotriazole phenyldifluoromethylphosphonic acids were found to be potent PTP-1B inhibitors. Molecular modeling on the X-ray crystal structure of the lead structure led to the design of potent PTP-1B inhibitors that show moderate selectivity against TC-PTP, a very closely related protein tyrosine phosphatase.
Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase IB (PTP-IB)
-
, (2008/06/13)
The invention encompasses the novel class of compounds represented by formula I which are inhibitors of the PTP-1B enzyme. The invention also encompasses pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases, including diabetes, obesity, and diabetes-related diseases.
Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
-
, (2008/06/13)
The invention encompasses the novel class of compounds represented by formula I, which are inhibitors of the PTP-1B enzyme. The invention also encompasses pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases, including diabetes, obesity, and conditions related to diabetes.
